Giant Biogene listed on the Hong Kong Stock Exchange

On November, 2022, Legend Capital portfolio company Giant Biogene (2367.HK) was successfully listed on the main board of the Hong Kong Stock Exchange. The number of Giant Biogene’s offer shares under the global offering is 22,608,800 shares at an issue price of HKUSD24.3 per share, which includes 2,261,200 Hong Kong offering shares, 20,347,600 international offering […]